Hedge Fund - Exome Asset Management
Eli Lilly & Co (LLY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $8,438,387 | 4.03% | 7,852 | $956.19 |
| 2 | 2025 - Q3 (2025-09-30) | $5,991,076 | 3.63% | 7,852 | $744.16 |
| 3 | 2025 - Q2 (2025-06-30) | $3,642,744 | 2.71% | 4,673 | $777.07 |
| 4 | 2025 - Q1 (2025-03-31) | $3,859,477 | 3.43% | 4,673 | $832.09 |
| 5 | 2024 - Q4 (2024-12-31) | $6,366,684 | 4.78% | 8,247 | $828.01 |
| 6 | 2024 - Q3 (2024-09-30) | $9,255,415 | 6.25% | 10,447 | $899.05 |
| 7 | 2024 - Q2 (2024-06-30) | $8,782,186 | 7.82% | 9,700 | $799.92 |
| 8 | 2024 - Q1 (2024-03-31) | $7,546,212 | 6.46% | 9,700 | $711.67 |
| 9 | 2023 - Q4 (2023-12-31) | $5,654,324 | 5.59% | 9,700 | $583.70 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center